Sunitinib Teva

Sunitinib Teva is an oral prescription medication used for treating certain types of cancer. It belongs to a class of drugs known as kinase inhibitors. This product is manufactured by Teva B.V and is available in the EU market.

Sunitinib Teva is primarily used to treat specific cancers, including gastrointestinal stromal tumors and advanced renal cell carcinoma. It may also be prescribed for pancreatic neuroendocrine tumors in certain cases. Patients often ask, 'what is Sunitinib used for' as it targets cancer cells by blocking signals that promote tumor growth. This medication is designed to slow the spread of cancer within the body.

Sunitinib Teva works by interfering with the growth of cancer cells, which may slow or stop their spread. Some patients may experience changes in energy levels or appetite while taking this medication. It is important to note that individual responses to the drug can vary widely.

Sunitinib Teva should be taken exactly as prescribed by a healthcare professional. Patients should discuss their full medical history with their doctor before starting treatment. Regular monitoring may be required to manage potential side effects. It is not recommended to adjust the dose without medical guidance.

Sunitinib Teva may interact with other medications, including certain antibiotics, antifungals, and herbal supplements. Combining it with grapefruit products could affect how the drug works in the body. Patients should inform their doctor about all medications and supplements they are taking to avoid potential interactions.